STOCKSCOUTER

StockScouter Premium

StockScouter Screener and Portfolios are now in our premium offering.
Learn more or Get it now! Stockscouter Portfolio performance

GKOS GLAUKOS CORPORATION StockScouter® Report

5

StockScouter® Score

GLAUKOS CORPORATION, a mid cap growth company in the healthcare sector, is expected to perform in line with the market over the next six months with slightly less than average risk

10 is the best possible rating. Learn more.

Summary

Positives

  • Earnings growth in the past year has accelerated moderately compared to earnings growth in the past three years. Positive
  • One or more less experienced analysts has modestly increased quarterly earnings estimates for GKOS. Positive/Neutral

 

Concerns

  • The enterprise value-to-sales ratio is much higher than the average for comparably-sized companies in the StockScouter universe. Very Negative
  • The multi-period measure of relative price change and consistency is well below average. Negative

 

Short-term Outlook

Over the next 1-2 months, StockScouter forecasts that mid cap stocks will be in favor, growth stocks will be neutral, and healthcare stocks will be in favor.

Expected Risk/Return

Progress: 40% done.
Progress: 60% done.
Low
High

Core Model Grades

B
C
F
F

Previous Ratings

5
5
4